These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 15532809)

  • 1. Preoperative chemoradiation therapy for low rectal cancer. Impact on downstaging and sphincter-saving operations.
    Habr-Gama A; Perez RO; Kiss DR; Rawet V; Scanavini A; Santinho PM; Nadalin W
    Hepatogastroenterology; 2004; 51(60):1703-7. PubMed ID: 15532809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal surgery time after preoperative chemoradiotherapy for locally advanced rectal cancers.
    Lim SB; Choi HS; Jeong SY; Kim DY; Jung KH; Hong YS; Chang HJ; Park JG
    Ann Surg; 2008 Aug; 248(2):243-51. PubMed ID: 18650634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant chemoradiation versus hyperfractionated accelerated radiotherapy in locally advanced rectal cancer.
    Ceelen W; Boterberg T; Pattyn P; van Eijkeren M; Gillardin JM; Demetter P; Smeets P; Van Damme N; Monsaert E; Peeters M
    Ann Surg Oncol; 2007 Feb; 14(2):424-31. PubMed ID: 17096057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The surgeon as prognostic factor for local recurrence and survival in the anal sphincter preservation for mid-rectal cancer.
    Luna-Pérez P; Reyna Huelga A; Labastida Almendaro S; Rodríguez-Coria DF; González Macouzet J; Delgado Gallardo S
    Rev Invest Clin; 1999; 51(4):205-13. PubMed ID: 10546501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between pathologic T-stage and nodal metastasis after preoperative chemoradiotherapy for locally advanced rectal cancer.
    Pucciarelli S; Capirci C; Emanuele U; Toppan P; Friso ML; Pennelli GM; Crepaldi G; Pasetto L; Nitti D; Lise M
    Ann Surg Oncol; 2005 Feb; 12(2):111-6. PubMed ID: 15827790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic value of lymph node metastases and tumour regression grade in rectal cancer patients treated with long-course preoperative chemoradiotherapy.
    Lindebjerg J; Spindler KL; Ploen J; Jakobsen A
    Colorectal Dis; 2009 Mar; 11(3):264-9. PubMed ID: 18573119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-operative chemo-radiotherapy improves the sphincter preservation rate in patients with rectal cancer located within 3 cm of the anal verge.
    Kim DW; Lim SB; Kim DY; Kim TH; Jung KH; Kim DH; Chang HJ; Sohn DK; Hong CW; Choi HS; Jeong SY; Park JG
    Eur J Surg Oncol; 2006 Mar; 32(2):162-7. PubMed ID: 16289718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The correlation between tumour regression grade and lymph node status after chemoradiation in rectal cancer.
    Berho M; Oviedo M; Stone E; Chen C; Nogueras J; Weiss E; Sands D; Wexner S
    Colorectal Dis; 2009 Mar; 11(3):254-8. PubMed ID: 18513188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sphincter preservation therapy for rectal cancer.
    Aitken C; Breen E; Mamon HJ
    Clin Adv Hematol Oncol; 2003 Dec; 1(12):735-40. PubMed ID: 16258478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sphincter preservation in low rectal cancer is facilitated by preoperative chemoradiation and intersphincteric dissection.
    Weiser MR; Quah HM; Shia J; Guillem JG; Paty PB; Temple LK; Goodman KA; Minsky BD; Wong WD
    Ann Surg; 2009 Feb; 249(2):236-42. PubMed ID: 19212176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative chemoradiotherapy and total mesorectal excision surgery for locally advanced rectal cancer: correlation with rectal cancer regression grade.
    Wheeler JM; Dodds E; Warren BF; Cunningham C; George BD; Jones AC; Mortensen NJ
    Dis Colon Rectum; 2004 Dec; 47(12):2025-31. PubMed ID: 15657650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoradiotherapy followed by surgery in rectal cancer: improved local control using a moderately high pelvic radiation dose.
    Lee SH; Lee KC; Choi JH; Oh JH; Baek JH; Park SH; Shin DB
    Jpn J Clin Oncol; 2008 Feb; 38(2):112-21. PubMed ID: 18263881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer.
    Das P; Skibber JM; Rodriguez-Bigas MA; Feig BW; Chang GJ; Wolff RA; Eng C; Krishnan S; Janjan NA; Crane CH
    Cancer; 2007 May; 109(9):1750-5. PubMed ID: 17387743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy comparison of neoadjuvant radiotherapy with or without chemotherapy for locally advanced rectal cancer].
    Wu B; Qiu HZ; Xiao Y; Lin GL; Niu BZ; Zhang FQ; Hu K
    Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Mar; 11(2):124-7. PubMed ID: 18344077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Squamous-cell carcinoma of the rectum: a rare but curable tumor.
    Nahas CS; Shia J; Joseph R; Schrag D; Minsky BD; Weiser MR; Guillem JG; Paty PB; Klimstra DS; Tang LH; Wong WD; Temple LK
    Dis Colon Rectum; 2007 Sep; 50(9):1393-400. PubMed ID: 17661147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of long-term follow-up for transanal excision for rectal cancer.
    Gonzalez QH; Heslin MJ; Shore G; Vickers SM; Urist MM; Bland KI
    Am Surg; 2003 Aug; 69(8):675-8; discussion 678. PubMed ID: 12953825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance imaging accuracy in assessing tumour down-staging following chemoradiation in rectal cancer.
    Suppiah A; Hunter IA; Cowley J; Garimella V; Cast J; Hartley JE; Monson JR
    Colorectal Dis; 2009 Mar; 11(3):249-53. PubMed ID: 18513192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.
    Liersch T; Langer C; Ghadimi BM; Kulle B; Aust DE; Baretton GB; Schwabe W; Häusler P; Becker H; Jakob C
    J Clin Oncol; 2006 Sep; 24(25):4062-8. PubMed ID: 16943523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient profile and treatment outcome of rectal cancer patients treated with multimodality therapy at a regional cancer center.
    Deo S; Kumar S; Shukla NK; Kar M; Mohanti BK; Sharma A; Raina V; Rath GK
    Indian J Cancer; 2004; 41(3):120-4. PubMed ID: 15472410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.